- Home
- MODD vs NTRB Comparison
MODD vs NTRB Comparison
Compare MODD & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MODD
- NTRB
- Stock Information
- Founded
- MODD 1998
- NTRB 2016
- Country
- MODD United States
- NTRB United States
- Employees
- MODD N/A
- NTRB N/A
- Industry
- MODD Industrial Specialties
- NTRB Industrial Specialties
- Sector
- MODD Health Care
- NTRB Health Care
- Exchange
- MODD Nasdaq
- NTRB Nasdaq
- Market Cap
- MODD 55.3M
- NTRB 59.1M
- IPO Year
- MODD N/A
- NTRB N/A
- Fundamental
- Price
- MODD $1.00
- NTRB $5.72
- Analyst Decision
- MODD
- NTRB Buy
- Analyst Count
- MODD 0
- NTRB 1
- Target Price
- MODD N/A
- NTRB $13.00
- AVG Volume (30 Days)
- MODD 95.0K
- NTRB 54.8K
- Earning Date
- MODD 06-20-2025
- NTRB 05-30-2025
- Dividend Yield
- MODD N/A
- NTRB N/A
- EPS Growth
- MODD N/A
- NTRB N/A
- EPS
- MODD N/A
- NTRB N/A
- Revenue
- MODD N/A
- NTRB $2,139,537.00
- Revenue This Year
- MODD N/A
- NTRB $571.50
- Revenue Next Year
- MODD N/A
- NTRB $577.37
- P/E Ratio
- MODD N/A
- NTRB N/A
- Revenue Growth
- MODD N/A
- NTRB 2.60
- 52 Week Low
- MODD $0.68
- NTRB $3.35
- 52 Week High
- MODD $2.65
- NTRB $11.78
- Technical
- Relative Strength Index (RSI)
- MODD 52.36
- NTRB 48.69
- Support Level
- MODD $0.97
- NTRB $5.51
- Resistance Level
- MODD $1.15
- NTRB $8.11
- Average True Range (ATR)
- MODD 0.09
- NTRB 0.57
- MACD
- MODD 0.01
- NTRB 0.05
- Stochastic Oscillator
- MODD 50.00
- NTRB 22.35
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.